Biohit - Innovating for Health

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit's mission is "Innovating for Health" - we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on NASDAQ OMX Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com
Financial calendar
02/20/2017 9:30  Financial Statement release 2016
03/31/2017 18:00  The date by which a shareholder can notify the company’s board of directors of an issue that he or she requests to be addressed at the general meeting
04/26/2017 17:00  Annual General Meeting
08/17/2017 9:30  Half year financial report for period January-June (H1) 2017
Major shareholders -  08/31/2017
 
 
Holdings, total
Holdings, %
1
Suovaniemi Osmo Antero
Holdings, total
3,230,567
Holdings, %
21.86
2
Interlab Oy
Holdings, total
2,034,497
Holdings, %
13.77
3
Suovaniemi Ville Roi
Holdings, total
579,580
Holdings, %
3.92
4
Joel Suovaniemi
Holdings, total
541,280
Holdings, %
3.66
5
Suovaniemi Oili
Holdings, total
400,535
Holdings, %
2.71
6
Genetic Analysis As
Holdings, total
338,363
Holdings, %
2.29
7
Härkönen Matti
Holdings, total
325,165
Holdings, %
2.20
8
Suovaniemi Vesa Jukka Markku
Holdings, total
262,619
Holdings, %
1.78
9
Oy Etra Invest Ab
Holdings, total
200,000
Holdings, %
1.35
10
Luostarinen Reijo
Holdings, total
110,000
Holdings, %
0.74
An Investis Flife service. © 2017
Investis